HomeComparePRVCF vs JNJ

PRVCF vs JNJ: Dividend Comparison 2026

PRVCF yields 14285.71% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PRVCF wins by $1868328188208921344.00M in total portfolio value
10 years
PRVCF
PRVCF
● Live price
14285.71%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1868328188208921344.00M
Annual income
$1,842,950,648,126,759,800,000,000.00
Full PRVCF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — PRVCF vs JNJ

📍 PRVCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPRVCFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PRVCF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PRVCF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PRVCF
Annual income on $10K today (after 15% tax)
$1,214,285.71/yr
After 10yr DRIP, annual income (after tax)
$1,566,508,050,907,746,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, PRVCF beats the other by $1,566,508,050,907,746,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PRVCF + JNJ for your $10,000?

PRVCF: 50%JNJ: 50%
100% JNJ50/50100% PRVCF
Portfolio after 10yr
$934164094104460672.00M
Annual income
$921,475,324,063,379,900,000,000.00/yr
Blended yield
98.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PRVCF
No analyst data
Altman Z
-138.3
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PRVCF buys
0
JNJ buys
0
No recent congressional trades found for PRVCF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPRVCFJNJ
Forward yield14285.71%2.14%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$1868328188208921344.00M$30.5K
Annual income after 10y$1,842,950,648,126,759,800,000,000.00$4,749.88
Total dividends collected$1866648039868218112.00M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PRVCF vs JNJ ($10,000, DRIP)

YearPRVCF PortfolioPRVCF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,439,271$1,428,571.43$10,594$274.49+$1.43MPRVCF
2$193,699,090$192,159,069.24$11,294$360.69+$193.69MPRVCF
3$24,376,441,818$24,169,183,791.94$12,133$476.91+$24376.43MPRVCF
4$2,868,716,750,186$2,842,633,957,441.24$13,156$635.42+$2868716.74MPRVCF
5$315,716,708,842,374$312,647,181,919,674.60$14,432$854.61+$315716708.83MPRVCF
6$32,495,195,455,130,188$32,157,378,576,668,850.00$16,056$1,162.76+$32495195455.11MPRVCF
7$3,128,044,259,554,657,300$3,093,274,400,417,667,600.00$18,175$1,604.53+$3128044259554.64MPRVCF
8$281,631,115,249,329,080,000$278,284,107,891,605,600,000.00$21,009$2,252.68+$281631115249329.06MPRVCF
9$23,717,327,179,590,366,000,000$23,415,981,886,273,583,000,000.00$24,911$3,229.73+$23717327179590368.00MPRVCF
10$1,868,328,188,208,921,400,000,000$1,842,950,648,126,759,800,000,000.00$30,458$4,749.88+$1868328188208921344.00MPRVCF

PRVCF vs JNJ: Complete Analysis 2026

PRVCFStock

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.

Full PRVCF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this PRVCF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PRVCF vs SCHDPRVCF vs JEPIPRVCF vs OPRVCF vs KOPRVCF vs MAINPRVCF vs ABBVPRVCF vs MRKPRVCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.